AstraZeneca investors punish firm over reports of $400-billion Bristol Myers pharma deal
- Posted on August 3, 2026
- By The Globe and Mail
- 0 Views
- 1 min read
In brief
Generating AI summary…
AstraZeneca investors punish firm over reports of $400-billion Bristol Myers pharma deal
Shares in AstraZeneca closed down some 9 per cent, the biggest drop since 2020
